Transcription of SMAD7 and S1PR1 is decreased in the peripheral blood CD4+ T lymphocytes of RRMS patients during acute relapses and in remitting phases, and in CD patients compared with healthy donors. Here, CD4 is linked to relapsing-remitting multiple sclerosis.